Junxiang Zeng

Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial–mesenchymal transition

Manxiu Huai, Junxiang Zeng, Wensong Ge · International Immunopharmacology · 2020 · 46 citations

Inflammation, M2 Phenotype, Cytokine +10

Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Bingxian Bian, Li Li, Junyao Yang et al. · Cancer Cell International · 2019 · 39 citations · Full text

Eugenol inhibits non‐small cell lung cancer by repressing expression of NF‐κB‐regulated TRIM59

Zhilei Cui, Zhen Liu, Junxiang Zeng et al. · Phytotherapy Research · 2019 · 36 citations

Lung‐specific exosomes for co‐delivery of <scp>CD47</scp> blockade and cisplatin for the treatment of non–small cell lung cancer

Zhilei Cui, Zhengshang Ruan, Junxiang Zeng et al. · Thoracic Cancer · 2022 · 21 citations · Full text

Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages

Zhilei Cui, Zhengshang Ruan, Meigui Li et al. · International Immunopharmacology · 2023 · 21 citations

Cancer Immunosurveillance, Intermittent Hypoxia, Pd-l1 Expression +10